October 18, 2024
Thyroid Disorders
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
September 27, 2024
FDA Approves Selpercatinib for RET Fusion–Positive Medullary Thyroid Cancer
The ASCO Post
Advertisement
Recommendations
Advertisement